In recent trading, CONMED Corp (Symbol: CNMD) shares reached $107.27, surpassing the average analyst 12-month target price of $100.50. Analysts now face decisions on whether to downgrade the stock or adjust their targets based on company performance. Current targets range from a low of $83.00 to a high of $108.00, with a standard deviation of $9.203.
Among six analysts covering CONMED, there are three “Strong Buy” ratings, one “Buy,” and three “Hold” ratings, indicating a generally positive outlook. The average rating remains stable at 2.0, where 1 denotes “Strong Buy” and 5 indicates “Strong Sell.”
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
